Deutsche Bank’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-215,905
| Closed | -$1.97M | – | 3710 |
|
|
2025
Q2 | $1.97M | Sell |
215,905
-8,077
| -4% | -$59.4K | ﹤0.01% | 1716 |
|
|
2025
Q1 | $1.78M | Buy |
223,982
+173,164
| +341% | +$1.27M | ﹤0.01% | 1832 |
|
|
2024
Q4 | $276K | Buy |
50,818
+20,504
| +68% | +$125K | ﹤0.01% | 2954 |
|
|
2024
Q3 | $219K | Buy |
30,314
+3,411
| +13% | +$31.2K | ﹤0.01% | 2886 |
|
|
2024
Q2 | $292K | Sell |
26,903
-1,003,592
| -97% | -$12.9M | ﹤0.01% | 2612 |
|
|
2024
Q1 | $19.3M | Buy |
1,030,495
+2,740
| +0.3% | +$63.2K | 0.01% | 827 |
|
|
2023
Q4 | $22.3M | Sell |
1,027,755
-546
| -0.1% | -$10.8K | 0.01% | 769 |
|
|
2023
Q3 | $21.2M | Sell |
1,028,301
-6,440
| -0.6% | -$186K | 0.01% | 687 |
|
|
2023
Q2 | $48.7M | Buy |
1,034,741
+257,328
| +33% | +$12.8M | 0.03% | 518 |
|
|
2023
Q1 | $32.6M | Buy |
777,413
+249,494
| +47% | +$10.7M | 0.02% | 638 |
|
|
2022
Q4 | $20.1M | Sell |
527,919
-30,949
| -6% | -$1.18M | 0.01% | 759 |
|
|
2022
Q3 | $21.9M | Sell |
558,868
-9,089
| -2% | -$351K | 0.01% | 736 |
|
|
2022
Q2 | $18.3M | Sell |
567,957
-11,385
| -2% | -$382K | 0.01% | 801 |
|
|
2022
Q1 | $19.2M | Sell |
579,342
-27,800
| -5% | -$1.05M | 0.01% | 848 |
|
|
2021
Q4 | $25.8M | Sell |
607,142
-24,945
| -4% | -$1.04M | 0.01% | 778 |
|
|
2021
Q3 | $28M | Buy |
632,087
+25,177
| +4% | +$1.15M | 0.01% | 777 |
|
|
2021
Q2 | $34.5M | Sell |
606,910
-35,627
| -6% | -$2.52M | 0.02% | 729 |
|
|
2021
Q1 | $48.1M | Sell |
642,537
-73,528
| -10% | -$6.03M | 0.03% | 602 |
|
|
2020
Q4 | $61.9M | Buy |
716,065
+441,228
| +161% | +$32.5M | 0.04% | 433 |
|
|
2020
Q3 | $16.8M | Sell |
274,837
-41,858
| -13% | -$2.12M | 0.01% | 765 |
|
|
2020
Q2 | $13.2M | Sell |
316,695
-122,863
| -28% | -$4.46M | 0.01% | 855 |
|
|
2020
Q1 | $12.6M | Buy |
439,558
+79,314
| +22% | +$4.59M | 0.01% | 837 |
|
|
2019
Q4 | $26M | Buy |
360,244
+235,590
| +189% | +$29M | 0.02% | 689 |
|
|
2019
Q3 | $17.5M | Sell |
124,654
-21,826
| -15% | -$3.65M | 0.01% | 834 |
|
|
2019
Q2 | $26.8M | Buy |
146,480
+67,147
| +85% | +$11.5M | 0.02% | 823 |
|
|
2019
Q1 | $12.6M | Sell |
79,333
-57,587
| -42% | -$8.34M | 0.01% | 1255 |
|
|
2018
Q4 | $13.1M | Sell |
136,920
-35,756
| -21% | -$4.09M | 0.01% | 1135 |
|
|
2018
Q3 | $24.4M | Sell |
172,676
-4,584
| -3% | -$708K | 0.01% | 1020 |
|
|
2018
Q2 | $27.7M | Sell |
177,260
-126,635
| -42% | -$19.9M | 0.01% | 984 |
|
|
2018
Q1 | $48.9M | Buy |
303,895
+152,116
| +100% | +$25.8M | 0.02% | 659 |
|
|
2017
Q4 | $25M | Sell |
151,779
-226,840
| -60% | -$22M | 0.02% | 873 |
|
|
2017
Q3 | $23.6M | Sell |
378,619
-281,794
| -43% | -$22.1M | 0.02% | 927 |
|
|
2017
Q2 | $52.6M | Sell |
660,413
-13,458
| -2% | -$973K | 0.04% | 500 |
|
|
2017
Q1 | $47.9M | Sell |
673,871
-229,764
| -25% | -$13.5M | 0.04% | 525 |
|
|
2016
Q4 | $46.1M | Sell |
903,635
-128,791
| -12% | -$6.07M | 0.04% | 518 |
|
|
2016
Q3 | $47.5M | Buy |
1,032,426
+615,414
| +148% | +$25M | 0.03% | 541 |
|
|
2016
Q2 | $12.6M | Buy |
417,012
+122,441
| +42% | +$4.08M | 0.01% | 1169 |
|
|
2016
Q1 | $9.44M | Buy |
294,571
+255,293
| +650% | +$8.99M | 0.01% | 1295 |
|
|
2015
Q4 | $2.29M | Buy |
39,278
+21,280
| +118% | +$1.05M | ﹤0.01% | 2341 |
|
|
2015
Q3 | $760K | Sell |
17,998
-2,680
| -13% | -$165K | ﹤0.01% | 3111 |
|
|
2015
Q2 | $1.51M | Sell |
20,678
-1,395
| -6% | -$89.7K | ﹤0.01% | 2689 |
|
|
2015
Q1 | $1.11M | Buy |
22,073
+9,395
| +74% | +$404K | ﹤0.01% | 2827 |
|
|
2014
Q4 | $463K | Sell |
12,678
-5,123
| -29% | -$191K | ﹤0.01% | 3730 |
|
|
2014
Q3 | $560K | Buy |
+17,801
| New | +$516K | ﹤0.01% | 3417 |
|
Other funds holding SAGE
IA
HNB
Deutsche Bank's SAGE Position: Q3 2025 in Review
Deutsche Bank sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 215,905 shares — an estimated $1.97M sold.
Deutsche Bank first reported a position in SAGE in Q3 2014 and held it in 44 quarters. The position peaked at $61.9M in Q4 2020. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Deutsche Bank reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Deutsche Bank sold 215,905 Sage Therapeutics shares in Q3 2025, an estimated $1.97M.
- Deutsche Bank first reported a position in Sage Therapeutics in Q3 2014 and held it in 44 quarters.
- Deutsche Bank's Sage Therapeutics position peaked at $61.9M in Q4 2020.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.